Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta1-adrenergic receptor polymorphisms in human right atrium in vitro

Journal of the American College of Cardiology

Volumn 40, Issue 7, 2002, Pages 1275-1282

  Molenaar, Peter ^a   Rabnott, Glenn ^b   Yang, Ian ^b   Fong, Kwun M ^b   Savarimuthu, Santiyagu M ^b   Li, Li ^a   West, Malcolm J ^a   Russell, Fraser D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOPRENALINE; METOPROLOL; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRATE; NORADRENALIN; PHENOXYBENZAMINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC STIMULATION; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART CONTRACTION; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE RELAXATION; HEART RIGHT ATRIUM; HEART STIMULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMINO ACID SUBSTITUTION; ATRIAL FUNCTION; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1; SYMPATHOMIMETICS; TIME FACTORS; VARIATION (GENETICS);

EID: 0037010032     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02137-X     Document Type: Article

References (17)

1. 1-adrenoceptor: identification and rapid screening assay. Lancet 1999;353:897.
2. 1-adrenergic receptor. J Biol Chem 1999;274:12670-4.
3. 1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 1999;31:1025-32.
4. 1-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000;21:1853-8.
5. 1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000;78:87-93.
6. Wagoner LE, Lamba S, Craft LL, et al. Polymorphic Gly389 β1 adrenergic receptors depress exercise capacity in heart failure (abstr). Circulation 2000;102:II378.
7. 1-adrenergic receptor gene and hypertension. Circulation 2001;104:187-90.
8. 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 2001;11:191-7.
9. 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001;11:199-205.
10. 1-adrenoceptor polymorphisms in human right atrium (abstr). Proc Aust Soc Med Res 40th Natl Sci Conf 2001:O-018.
11. 2-adrenoceptors in human atrial myocardium. Circ Res 1990;66:1610-23.
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
13. 1-adrenoceptor gene variant compared to G389 variant in isolated human atrial myocardium (abstr). Circulation 2001;104:II61-2.
14. 1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci 2000;99:233-8.
15. 2-muscarinic receptors in the human right atrium. Br J Pharmacol 1990;101:363-9.
16. 3-adrenoceptors. Br J Pharmacol 1997;120:165-76.
17. 1-receptor down-regulation in heart failure. Circ Res 1986;59:297-309.